One thing that the Coronavirus pandemic has sharply put in focus for many of us is our health. Now every cough or sniffle, you question whether or not you have been hit by COVID-19 or if it is just another cold. Either way, you are armed with your thermometer, your vitamin C, chicken soup and keeping your family members at bay. You are taking every precaution in ways that you would have not normally taken before and you may also be looking at alternatives to traditional meds, like cannabis.

Continue reading

For many 2020 has been the year of giant tidal shifts, uncertainty and complete unpredictability. This was especially evident in the Cannabis space where the challenges of constantly shifting regulatory issues piled on top of the vape crisis just to be outshined by the Coronavirus pandemic related shutdowns and retail limitations, a business problem only closely supercharged by political shifts. Nothing was predictable; as the country began to shut down, and everyone buckled down, just to see the biggest spike in sales in March of 2020 as the consumers prepared for the long haul. Then as the industry prepared for the 4/20 retail rush, a big ooops – no expected spike or the revenues to show for it. Everything was upside down and all this had an obvious negative impact business, investment activities, growth and expansion.

Continue reading

While some might say that the ability to launch new products is the “American Dream” and allows for innovation, others might argue that when you launch a “healthcare” product that consumers are going to be putting in their bodies, you should have all the research to prove that there is no harm.

Continue reading